NBY•benzinga•
NovaBay Pharmaceuticals's Return On Capital Employed Insights
Summary
Benzinga Pro data, NovaBay Pharmaceuticals (AMEX:NBY) reported Q2 sales of $3.04 million. Earnings fell to a loss of $2.15 million, resulting in a 1841.44% decrease from last quarter.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 8, 2022 by benzinga